The WATCHMAN Choice
"It's peace of mind. It's just such a good feeling."
Marjorie Giovannoni, WATCHMAN recipient
Richard developed a hematoma in his abdomen, which then caused a crushing of the femoral nerve and a damage to the leg that restricted him completely on mobility in 2010. The hematoma was developed through long-term anti-coagulant use, so it was strongly recommended to him to cease any anti-coagulant. Richard discussed his options with his cardiologist who recommended a left atrial appendage closure therapy.
(Video length: 5:19)
Judith was diagnosed with atrial fibrillation and while waiting for ablation, she had a small stroke. She was put on warfarin, but had another small stroke so they took her off warfarin, but she had a major stroke that paralysed down her left side. Judith discussed left atrial appendage closure therapy option with her doctor. See her story.
(Video length: 7:37)
WATCHMAN is for people with atrial fibrillation not caused by a heart valve problem who need an alternative to oral anticoagulants. This website is intended to provide patients and caregivers with some information about the WATCHMAN Implant. It may help prepare you for talking to your doctor about your options for reducing stroke risk.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for the use only in countries with applicable health authority product registrations.
Content of this website is for Information Purposes only and not meant for product promotion or medical diagnostic. This information does not constitute medical or legal advice, and BSC makes no representation or warranty regarding this information or its completeness, accuracy or timeliness.
Accordingly, BSC strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.
- National Stroke Association. Making the Afib-Stroke Connection. https://www.stroke.org/sites/default/files/resources/Afib-Connection%20for%20hcp.pdf. Published 2012. Accessed September 1, 2016.
- Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1-12.
- Holmes DR Jr, Doshi SK, Kar S, et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2015;65(24):2614-2623.
- Price MJ, Reddy VY, Valderrábano M, et al. Bleeding outcomes after left atrial appendage closure compared with long-term warfarin. JACC Cardiovasc Interv. 2015;8(15):1925-1932.